Spect Inc., operating under the slogan "Eyecare, Anywhere.", is a pioneering company in the realm of data science, specifically targeting the health care sector. Founded in 2017 and headquartered in the United States, Spect aims to transform the landscape of eye disease prevention and healthcare data analytics. By leveraging advanced tools rooted in AI, the company provides a comprehensive solution for the early detection of eye diseases, notably diabetic retinopathy, glaucoma, and age-related macular degeneration, while also predicting whole-body conditions like stroke and Parkinson's.
The unique proposition of their human-in-the-loop telemedicine platform is its ability to produce diagnostic reports in minutes, which substantially enhances patient outcomes and financial metrics for clinics. The company successfully closed a $3.50M Seed Round on 30 November 2021, attracting notable investors including AME Cloud Ventures, Morado Ventures, 10x Group, and XTX Ventures, underscoring the potential for growth and impact.